European scientists have shed new light on how the influenza virus hijacks the cell production machinery of its host. Their findings could lead to the development of new drugs to combat influenza pandemics in the future. The work was supported by the European Union-funded FLUPOL project, which is financed by the EU to the tune of 1.97 million euros ($3.1 million).
One of the greatest fears among both governments and health agencies is of a devastating flu pandemic. They are worried that highly virulent strains of bird flu, like H5N1, may develop the ability to spread from human to human. As a result, new treatments and methods are being sought to halt the spread of the virus.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze